Insulet Corp. (PODD)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Insulet Corp. (PODD)
Go deeper and ask any question about PODD
Company Performance
Current Price
as of Sep 17, 2024$235.54
P/E Ratio
42.77
Market Cap
$16.52B
Description
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
Metrics
Overview
- HQActon, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerPODD
- Price$235.54+0.71%
Trading Information
- Market Cap$16.52B
- Float99.33%
- Average Daily Volume (1m)804,215
- Average Daily Volume (3m)752,516
- EPS$5.65
Company
- Revenue$1.87B
- Rev Growth (1yr)23.20%
- Net Income$188.60M
- Gross Margin68.41%
- EBITDA Margin15.11%
- EBITDA$73.80M
- EV$15.47B
- EV/Revenue8.26
- P/E42.77
- P/S9.28
Documents
SEC Filings
Earnings Calls